Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANTHARIDIN Cause Product communication issue? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product communication issue have been filed in association with CANTHARIDIN (YCANTH). This represents 5.3% of all adverse event reports for CANTHARIDIN.

6
Reports of Product communication issue with CANTHARIDIN
5.3%
of all CANTHARIDIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product communication issue From CANTHARIDIN?

Of the 6 reports.

Is Product communication issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANTHARIDIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CANTHARIDIN Cause?

Application site vesicles (50) Application site pain (35) Blister (23) Pain (10) Off label use (6) Accidental exposure to product (5) Anogenital warts (5) Skin plaque (5) Vulvovaginal pain (5)

What Other Drugs Cause Product communication issue?

EVOLOCUMAB (2,341) SEMAGLUTIDE (842) ERENUMAB-AOOE (598) SOMATROPIN (350) PEGFILGRASTIM (333) ETANERCEPT (122) ALBUTEROL (121) NIRMATRELVIR\RITONAVIR (70) DENOSUMAB (68) LEVODOPA (61)

Which CANTHARIDIN Alternatives Have Lower Product communication issue Risk?

CANTHARIDIN vs CAPECITABINE CANTHARIDIN vs CAPIVASERTIB CANTHARIDIN vs CAPLACIZUMAB CANTHARIDIN vs CAPLACIZUMAB-YHDP CANTHARIDIN vs CAPMATINIB

Related Pages

CANTHARIDIN Full Profile All Product communication issue Reports All Drugs Causing Product communication issue CANTHARIDIN Demographics